English | Español
Erianne Leatherman | Apr 5, 2017

BMS, Foundation Medicine partner on predictive biomarker project
Erianne Leatherman | Apr 5, 2017

Sanofi Genzyme expands Multiple Myeloma Journey Partners program

Erianne Leatherman | Apr 3, 2017

Symproic receives approval with U.S. launch expected this summer

Erianne Leatherman | Mar 31, 2017

Sanofi experiment uncovers daily impact of allergy symptoms
Erianne Leatherman | Mar 30, 2017

Study shows Type 2 diabetes treatment with SGLT-2 inhibitors slashes mortality, hospitalization
Erianne Leatherman | Mar 29, 2017

AbbVie, actress Julianne Hough partner on endometriosis campaign
Erianne Leatherman | Mar 24, 2017

Arriva Medical considering appeal options following court's ruling

Erianne Leatherman | Mar 21, 2017

FDA, EMA agree to review three Pfizer and Merck drugs for type 2 diabetics

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

Coalition warns against potential impact of H.R. 1 on patient healthcare access